Compare GALT & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GALT | INSW |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.2M | 4.1B |
| IPO Year | 2008 | 2016 |
| Metric | GALT | INSW |
|---|---|---|
| Price | $2.52 | $78.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $8.50 | ★ $77.00 |
| AVG Volume (30 Days) | 357.8K | ★ 549.1K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 5.39% |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ 5.75 |
| Revenue | N/A | ★ $843,302,000.00 |
| Revenue This Year | N/A | $10.20 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.43 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.27 | $35.60 |
| 52 Week High | $7.13 | $92.66 |
| Indicator | GALT | INSW |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 42.44 |
| Support Level | $2.62 | $65.42 |
| Resistance Level | $3.41 | $92.66 |
| Average True Range (ATR) | 0.22 | 2.88 |
| MACD | 0.05 | -1.45 |
| Stochastic Oscillator | 55.77 | 22.16 |
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. Its fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.